Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Autologous CD1c (BDCA-1)+ myDC |
Synonyms | |
Therapy Description |
Autologous CD1c (BDCA-1)+ MyDC are patient-derived myeloid dendritic cells expressing CD1c (BDCA-1), which potentially enhance antitumor immune response and inhibit tumor growth (PMID: 38212127). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Autologous CD1c (BDCA-1)+ myDC | Autologous CD1c (BDCA-1)+ MyDC are patient-derived myeloid dendritic cells expressing CD1c (BDCA-1), which potentially enhance antitumor immune response and inhibit tumor growth (PMID: 38212127). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|